Bearing in mind that most of the prospective approaches for DMD rely on the use of only partially functional truncated dystrophins or utrophins, we compare here the sequence and structure of these proteins, highlighting importance of distinct regions and domains in the therapeutic context. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.